Navigation Links
Dempsey Challenge Participant Registration Officially Open
Date:2/1/2010

LEWISTON, Maine, Feb. 1 /PRNewswire/ -- Registration for the second annual Dempsey Challenge presented by Amgen is officially open and are accepted through the event website www.dempseychallenge.org . The non-competitive, fundraising event serves as the primary fundraiser for The Patrick Dempsey Center for Cancer Hope & Healing at Central Maine Medical Center, in Lewiston, ME, which provides free support, education and wellness services to cancer patients, survivors and caregivers.

(Photo:  http://www.newscom.com/cgi-bin/prnh/20100201/CL46913 )

Due to the popularity of the inaugural event, the Challenge has been expanded to a two-day format featuring run/walk distances of 5K and 10K on Saturday, Oct. 2 and cycling distances of 10, 25, 50 and 100-miles on Sunday, Oct. 3.  Participant caps of 4,000 have been set for the run/walk and 3,500 for cycling. Each event will begin and end at Simard-Payne Police Memorial Park in Lewiston, Maine.

Dempsey Challenge event organizers are focused on providing an exceptional experience for everyone involved, as well as raising needed funds to aid the Dempsey Center. In addition to the required entry fee of $35 for the run/walk and $75 for cycling, a req
'/>"/>

SOURCE The Patrick Dempsey Center for Cancer Hope & Healing
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. NDIA's Biometrics Conference to Address Practical Approaches to the President's Challenge of 'Connecting the Dots' and Implementing $1B for New and Additional Security
2. Industry Forms Association to Address Opportunities and Challenges of Synthetic Biology
3. New Jerseys Best and Brightest Minds Discuss Challenges Facing Medical Innovation, Call for Policies to Preserve U.S. Leadership in Research and Development
4. Frost & Sullivan Reveals Strategies on Turning Challenges into Opportunities in the European Biomarkers Market
5. Is your microrobot up for the (NIST) challenge?
6. Thomson Reuters Explores the Opportunities and Challenges of Entering the Japanese Generic Drug Market
7. The National Park Foundation and Olympus Announce Winner of the First-Ever Your Parks Video Challenge
8. Will Jatropha Become a 'DotCom Bubble' in Biofuel Industry? Leading to 2nd JatrophaWorld Africa, Jatropha Webinar on 30 Sept 09 Explores Challenges & Offers Strategies for Long-Term Success for This Non-Food Crop for Fuel
9. TechConnect World 2010 Solving Global Technology Challenges with Clean Technology, Nanotechnology and Biotechnology
10. New Call Center Helps Ovarian Cancer Patients Cope With Challenges of Diagnosis
11. U.S. Federal Trade Commission to Challenge Thoratecs Proposed Acquisition of HeartWare International
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... England , May 22, 2013 ... novel drug-only formulation of glycopyrronium bromide designed using Prosonix, ... pharmaceutical company developing a portfolio of inhaled Respiratory ... clinical study with PSX1002 that will assess its effect ... of doses in patients with moderate to severe chronic ...
(Date:5/21/2013)... (PRWEB) May 21, 2013 Custom ... to reporting eLearning solution using Tin Can API ... dashboard tool. CLD is a leading developer of ... medical device companies worldwide. , Tin Can ... that helps learners and trainers more accurately measure ...
(Date:5/21/2013)... Alpha Source, Inc., a Wisconsin-based ... exhibiting for the 13th consecutive year at the ... 2013 Conference and Expo. The conference brings together ... healthcare technologies. This year’s event will be held ... , The three-day event draws over 1,500 healthcare ...
(Date:5/21/2013)... 21, 2013 Clinverse, Inc. ... for clinical trials, announced today it has formed ... Clinverse’s ClinPay® FLS eClinical commerce platform aggregates ... SpendMD ™, Aggregate Spend Solutions’ recently-launched ... tracking and reporting transfer of value at investigator ...
Breaking Biology Technology:Prosonix Initiates Phase 2 Clinical Study with PSX1002 in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) 2Prosonix Initiates Phase 2 Clinical Study with PSX1002 in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) 3Prosonix Initiates Phase 2 Clinical Study with PSX1002 in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) 4CLD Integrates Tin CAN API with its eLearning Solutions and Launches its Excelerometer Tracking Statement Dashboard 2CLD Integrates Tin CAN API with its eLearning Solutions and Launches its Excelerometer Tracking Statement Dashboard 3Alpha Source, Inc. to Exhibit at the AAMI 2013 Conference and Expo 2Clinverse, Inc. Announces Strategic Alliance with Aggregate Spend Solutions, LLC 2Clinverse, Inc. Announces Strategic Alliance with Aggregate Spend Solutions, LLC 3
... -- A new type of active metamaterial that incorporates ... ability to have power gain while retaining its negative ... research. "Our simulation and experimental results show that ... only provided gain, but also maintained the negative index ...
... 9, 2011 ARUP Laboratories, pathologist, Ronald L. Weiss, ... the College of American Pathologists at CAP ,11, the ... According to the CAP, the award honors members "who ... care through the specialty of pathology." (Logo: ...
... NewCardio, Inc., (OTC BB: NWCI) a cardiovascular diagnostic ... will utilize QTinno®, NewCardio,s automated cardiac safety solution, to ... drug under development for a central nervous system (CNS) ... important aspect of the trial. Clinilabs, located ...
Cached Biology Technology:New metamaterial allows transmission gain while retaining negative refraction property 2ARUP Laboratories' Pathologist, Ronald L. Weiss, MD, Honored With Lifetime Achievement Award for Contributions to Patient Care and Pathology 2Clinilabs will Conduct Phase 1 Trial Using QTinno® 2Clinilabs will Conduct Phase 1 Trial Using QTinno® 3Clinilabs will Conduct Phase 1 Trial Using QTinno® 4Clinilabs will Conduct Phase 1 Trial Using QTinno® 5
(Date:5/22/2013)... screening for prostate cancer could become as easy for ... to UC Irvine research published today in the ... more than a decade of work, UC Irvine chemists ... markers for prostate cancer in urine, meaning that the ... and at dramatically lower cost. The same technology could ...
(Date:5/21/2013)... have known for a long time that some creatures ... understood, particularly for plants. But it may be that ... National University and the U. S. National Evolutionary Synthesis ... 21 May in the journal Nature Communications , ... genomes. , Drawing from a database of global patterns ...
(Date:5/21/2013)... Wash. A new analysis shows that the nation,s ... of enough algae to produce up to 25 billion ... States, one-twelfth of the country,s yearly needs. , The ... resources that would be needed to grow significant amounts ... results were published in the May 7 issue of ...
Breaking Biology News(10 mins):UCI chemists devise inexpensive, accurate way to detect prostate cancer 2UCI chemists devise inexpensive, accurate way to detect prostate cancer 3Small but speedy: Short plants live in the evolutionary fast lane 2Going green: Nation equipped to grow serious amounts of pond scum for fuel 2Going green: Nation equipped to grow serious amounts of pond scum for fuel 3Going green: Nation equipped to grow serious amounts of pond scum for fuel 4
... NARRAGANSETT, R.I. August 30, 2010 The ... the University of Rhode Island Graduate School of ... Foundation (NSF) RAPID Response grant through the Foundation,s ... NSF grant, Improving Communication of Oil Spill Research, ...
... It is not an easy task to compare the ... by conventionally fuelled automobiles. The degree to which manufacture, ... the necessary electrical energy are detrimental to the environment ... a team of Empa scientists have made a detailed ...
... MADISON, WI, August 30th, 2010 Undergrads often take ... Iowa State University Department of Horticulture teamed up with ... section to teach students to research and understand literature ... Andrea L. Dinkelman, Jeanine E. Aune, and Gail R. ...
Cached Biology News:Metcalf Institute wins NSF grant to help journalism and communication of oil spill research 2'Greener' than expected 2'Greener' than expected 3Teaching communication and information literacy skills 2
Rabbit polyclonal to Shigella (HRP) ( Abpromise for all tested applications)....
Rabbit polyclonal to Aortic Elastin ( Abpromise for all tested applications). entrezGeneID: 2006 SwissProtID: P15502...
Rabbit polyclonal to GPR56 ( Abpromise for all tested applications). entrezGeneID: 9289 SwissProtID: Q9Y653...
Mouse monoclonal [2A4] to Cytokeratin 8 + 18 + 19 ( Abpromise for all tested applications). Antigen: Cytokeratins isolated from cultured pig kidney epithelial cells. Entrez GeneID: 3856 S...
Biology Products: